[HTML][HTML] Bisphosphonate conjugation for bone specific drug targeting

KB Farrell, A Karpeisky, DH Thamm, S Zinnen - Bone reports, 2018 - Elsevier
Bones provide essential functions and are sites of unique biochemistry and specialized
cells, but can also be sites of disease. The treatment of bone disorders and neoplasia has …

[HTML][HTML] Artificial intelligence in detection, management, and prognosis of bone metastasis: a systematic review

GF Papalia, P Brigato, L Sisca, G Maltese, E Faiella… - Cancers, 2024 - mdpi.com
Simple Summary Bone metastases represent a serious and common challenge in advanced
cancer patients, making early detection crucial. The growing implementation of artificial …

Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study

S Hong, T Youk, SJ Lee, KM Kim, CM Vajdic - PLoS One, 2020 - journals.plos.org
Bone is one of the most common sites of metastasis from advanced solid tumors. Bone
metastasis is a leading cause of pain and increases the risk of skeletal-related events …

[HTML][HTML] Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study

JF Huang, J Shen, X Li, R Rengan… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background Bones are one of the most common metastatic sites for solid malignancies.
Bone metastases can significantly increase mortality and decrease the quality of life of …

[HTML][HTML] Immune system and bone microenvironment: Rationale for targeted cancer therapies

A Gnoni, O Brunetti, V Longo, A Calabrese, R Calbi… - Oncotarget, 2020 - ncbi.nlm.nih.gov
Osteoimmunology was coined about twenty years ago to identify a strict cross talk between
bone niche and immune system both in physiological and pathological activities, including …

Incidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patients

M Harries, A Taylor, L Holmberg, O Agbaje… - Cancer …, 2014 - Elsevier
Background: Bone is the most common metastatic site associated with breast cancer. Using
a database of women with breast cancer treated at Guy's Hospital, London 1976–2006 and …

[HTML][HTML] Bone metastasis from gastric cancer: the incidence, clinicopathological features, and influence on survival

FP Turkoz, M Solak, S Kilickap, A Ulas… - Journal of Gastric …, 2014 - synapse.koreamed.org
Purpose To evaluate the incidence, clinicopathological characteristics, treatment outcomes,
prognostic factors, and survival of gastric cancer patients with bone metastases. Materials …

Bone targeted nano-drug and nano-delivery

Y Wu, B Sun, Y Tang, A Shen, Y Lin, X Zhao, J Li… - Bone Research, 2024 - nature.com
There are currently no targeted delivery systems to satisfactorily treat bone-related
disorders. Many clinical drugs consisting of small organic molecules have a short circulation …

Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients

SM Lim, YN Kim, KH Park, B Kang, HJ Chon, C Kim… - BMC cancer, 2016 - Springer
Background Bone metastasis is relatively uncommon in gastric cancer patients, but its
incidence has been rising. Early detection of bone metastasis is important in preventing …

Skeletal metastases of unknown primary: biological landscape and clinical overview

A Argentiero, AG Solimando, O Brunetti, A Calabrese… - Cancers, 2019 - mdpi.com
Skeletal metastases of unknown primary (SMUP) represent a clinical challenge in dealing
with patients diagnosed with bone metastases. Management of these patients has improved …